Companies
Charles River Laboratories
Life sciences toolsWilmington, MassachusettsCRLAbout 19,700 employees
More about Charles River Laboratories
Contract research company providing research models, preclinical safety testing and manufacturing support to drug developers
Revenue
$4.02B
Fiscal 2025, down about 1%
Employees
About 19,700
As of December 2025
Stock
CRL
New York Stock Exchange
Headquarters
Wilmington, Massachusetts
CEO
Birgit Girshick
Since May 2026, succeeding James Foster
Main businessesResearch models and services, discovery and safety assessment, manufacturing solutions
Current strategyRunning a strategic review of its portfolio, closing some sites, while offering an integrated drug discovery and preclinical services lineup
Recent workforce changesAbout 20 roles cut with the closure of its Hanover, Maryland cell therapy site announced in February 2026
CompetitorsInotiv, Labcorp, WuXi AppTec
Related companiesIQVIALabcorpThermo Fisher Scientific
Checked October 11, 2026 · Sources: sec.gov, nasdaq.com, nbcboston.com
No source-backed updates for Charles River Laboratories yet. They appear here when a public report or filing covers the company.
No one has posted about Charles River Laboratories yet. Be the first to post ›
Follow Charles River Laboratories in a feed reader, no account needed: RSS feed